>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: BDE +15.2%, HCCI +14.4%, NES +7.1%, JMEI +6.7%,KVHI +6%, DSW +5.3%, SSH +4.4%, CDTI +4.1%, BURL +3.4%, LJPC +3.1%, QUNR +3.1%, CUI+1.6%, LEU +1%, ROSG +0.6%, .

M&A news: BHP +1.1% (recommended shareholders approve the proposed demerger of South32)

Select airline related names showing strength: JBLU +2.2%, LUV +2.1%, DAL +1.8%, SAVE+1.5%

Other news: BDE +15.2% (announced that it has engaged the financial advisory firms Rothschild Inc. and Robert W. Baird & Co. to lead the exploration of a full range of strategic alternatives for each of its brands; co also reported earnings), CNET +13.3% (has committed a cash investment for an ~10% ownership stake in O'Yummy Investment Management), IMNP +9.6% (to develop a novel topical nanoparticle formulation of AmiKet), FISI +7.3% (filed for $100 mln mixed securities shelf offering), AAL+5.6% (to replace AGN in the S&P 500), CLDX +5.3% (announces clinical trial collaboration with Roche to evaluate the combination of Varlilumab and MPDL3280A), AMRN +2.5% (announced the presentation of findings from a new in vitro study showing that pretreatment with eicosapentaenoic acid reduced oxidation of small dense LDL and resulted in improved endothelial function), MVIS +2.5% (cont strength), NXTD +1.6% (announced it has shipped Wocket smart wallets today), NUS +1.5% (received approval from China's Ministry of Commerce for the company to commence direct selling activities in Shaoxing City in Zhejiang Province), KIN +0.9% (announced positive results of pilot field study of KIND-012 for the control of fever in horses; Randomized, blinded, placebo-controlled Phase 2 study meets its primary endpoint)

Analyst comments: CNAT +4.1% (reinstated with a Buy at ROTH Capital), ATHM +0.9% (upgraded to Overweight from Equal Weight at Barclays), LXP +0.6% (upgraded to Buy from Neutral at Ladenburg Thalmann)

>>> COP US : Provides 2015 to 2017 Capital Budget and Growth Outlook; Believes i

Provides 2015 to 2017 Capital Budget and Growth Outlook; Believes it Prudent to Position Co for Lower, More Volatile Commodity Prices for Forseeable Future 

ConocoPhillips (NYSE: COP) today announced its 2015 to 2017 capital budget and growth outlook. Details of the 2015 to 2017 plan will be reviewed at the companys upcoming Analyst and Investor Meeting on April 8, 2015.

For the past three years, ConocoPhillips has consistently delivered our stated objectives against a backdrop of relatively high, stable commodity prices, said Ryan Lance, chairman and chief executive officer. As commodity prices declined in late 2014, we took decisive action to adjust our 2015 spending. We now believe it is prudent to position the company for lower, more volatile prices for the foreseeable future. Our new plan will continue to focus on delivering a compelling dividend, while also achieving sustainable, modest volume growth and competitive returns. We strongly believe this is an attractive formula for shareholders and we look forward to sharing the details of our plans.

>>> US Early premarket gappers

Early premarket gappers
Gapping up: HCCI +14.4%, BDE +10.1%, SSH +9.2%, IMNP +9%, FISI +7.3%, DSW +7.2%, KVHI +6%, NES +5.8%, ZBRA +5.7%, MVIS +4.1%, AAL +3.9%, AAL +3.9%, BURL +3.4%, LJPC +3.1%, QUNR +3.1%, AMRN +2.8%, NUS +2.7%, JMEI +2.1%, NXTD +1.6%, JBLU +1.6%, CUI +1.6%, CTIC +1.5%, LUV +1.1%, LEU +1%, KIN +0.9%, ROSG+0.6%

Gapping down: MCP -21.6%, DSCO -21.3%, BOOM -12%, WTW -10.9%, PLUG -10.9%, CALL -10.6%, XONE -7.6%, NOAH -6.8%, JKS -5.6%, ABIO -4.9%, CRZO -4.8%, STEM -4.8%, WYY -4.8%, EGY -3.8%, JMBA -3.3%, ALU -3.3%, ICPT -3.2%, QGEN -3.1%, WD -3%, VEC -2.8%, ORAN -2.7%, BDSI -2.7%, MYE -2.5%, LNKD -2.4%, ARMH -2.3%,RTRX -2.2%, KCAP -1.9%, BCS -1.9%, MBLY -1.9%, OMER -1.6%, IOC -1.4%, NOK -1.3%, SHPG -1.3%, RSPP -1.3%, GILD -1.2%, CCL -1.2%, AEG -1.1%, RCL -1.1%, ALV -1%, VOD -1%, AIQ -1%